3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Breast Neoplasms
8
Prostatic Neoplasms
3
Thyroid Neoplasms
2
Neoplasm Metastasis
2
Carcinoma, Non-Small-Cell Lung
2
Urogenital Neoplasms
1
Thyroid Nodule
1
Thyroid Diseases
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma
1
Prostatic Diseases
1
Parotid Gland Neoplasms
1
Pancreatic Neoplasms
1
Neoplasms by Site
1
Neoplasms
1
Melanoma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hodgkin Disease
1
Histiocytoma, Malignant Fibrous
1
Head and Neck Neoplasms
1
Genital Neoplasms, Male
1
Disease
1
Carcinoma, Signet Ring Cell
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Neoplasms, Male
1
Interventions
pembrolizumab
23
Nivolumab
22
aldesleukin
21
Cyclophosphamide
20
Ipilimumab
17
Interleukin-2
17
fludarabine
15
fludarabine phosphate
14
cemiplimab
12
Radiotherapy
7
Fluorouracil
7
Dacarbazine
6
binimetinib
5
Vemurafenib
5
Temozolomide
5
Surgical Procedures, Operative
5
Sirolimus
5
Radiation
5
Biopsy
5
Aminolevulinic Acid
5
encorafenib
4
dabrafenib
4
Photochemotherapy
4
Educational Status
4
trametinib
3
sonidegib
3
montanide ISA 51
3
avelumab
3
Tacrolimus
3
Sodium Chloride
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Skin Neoplasms
×
Biopsy, Needle
×
Clear all
NCT00715793
2017-10-03
UPCI-07-008
University of Pittsburgh
Phase 1/2
Completed
39 enrolled
12 charts